180 related articles for article (PubMed ID: 22739729)
1. Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis.
Zhan Y; Sun HL; Chen H; Zhang H; Sun J; Zhang Z; Cai DH
Med Sci Monit; 2012 Jul; 18(7):BR286-91. PubMed ID: 22739729
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway.
Zhang Z; Yang L; Lei L; Chen R; Chen H; Zhang H
Int J Mol Med; 2016 Oct; 38(4):1161-9. PubMed ID: 27574116
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis.
Yang G; Huang Y; Wu X; Lin X; Xu J; Chen X; Bai X; Li Q
Biomed Res Int; 2018; 2018():8216578. PubMed ID: 29850572
[TBL] [Abstract][Full Text] [Related]
4. [Role of p38MAPK/eNOS signaling pathway in the inhibition of AGEs-induced apoptosis of human umbilical vein endothelial cells by glucagon-like peptide-1].
Zeng H; Huang Z; Zhang Y; Sun H
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):116-9, 139. PubMed ID: 26806750
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor protects against apoptosis induced by advanced glycation end products in endothelial cells.
Zhou YJ; Wang JH; Zhang J
Chin Med Sci J; 2006 Mar; 21(1):6-10. PubMed ID: 16615276
[TBL] [Abstract][Full Text] [Related]
6. [Effect of GLP-1 on high glucose-induced human umbilical vein endothelial cell apoptosis and mechanism].
Yuan X; Chen K; He H; Zhao L; Mo Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 38(10):1029-34. PubMed ID: 24164877
[TBL] [Abstract][Full Text] [Related]
7. [Involvement of p38 MAPK pathway in GLP-1-induced inhibition of apoptosis in human umbilical vein endothelial cells].
Xu H; Li HL; Niu ZY; Li GZ; Cao J; Jiang YD
Sheng Li Xue Bao; 2012 Aug; 64(4):444-8. PubMed ID: 22907305
[TBL] [Abstract][Full Text] [Related]
8. Methylglyoxal-derived hemoglobin advanced glycation end products induce apoptosis and oxidative stress in human umbilical vein endothelial cells.
Lee JH; Samsuzzaman M; Park MG; Park SJ; Kim SY
Int J Biol Macromol; 2021 Sep; 187():409-421. PubMed ID: 34271050
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products.
Zhang SS; Wu Z; Zhang Z; Xiong ZY; Chen H; Huang QB
Biochem Biophys Res Commun; 2017 Jan; 482(4):1413-1419. PubMed ID: 27965099
[TBL] [Abstract][Full Text] [Related]
10. Far-infrared protects vascular endothelial cells from advanced glycation end products-induced injury via PLZF-mediated autophagy in diabetic mice.
Chen CH; Chen TH; Wu MY; Chou TC; Chen JR; Wei MJ; Lee SL; Hong LY; Zheng CM; Chiu IJ; Lin YF; Hsu CM; Hsu YH
Sci Rep; 2017 Jan; 7():40442. PubMed ID: 28071754
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-Gallate Ameliorates Angiotensin II-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells through the Activation of Nrf2/Caspase-3 Signaling.
Zhou X; Liang L; Zhao Y; Zhang H
J Vasc Res; 2017; 54(5):299-308. PubMed ID: 28942440
[TBL] [Abstract][Full Text] [Related]
12. α-Mangostin protects against high-glucose induced apoptosis of human umbilical vein endothelial cells.
Luo Y; Lei M
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054969
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor protects human endothelial cells against advanced glycation end products-induced apoptosis.
Zhou YJ; Wang JH; Zhang J
Biochem Biophys Res Commun; 2006 Jun; 344(2):658-66. PubMed ID: 16630544
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15.
Puddu A; Storace D; Durante A; Odetti P; Viviani GL
Biochem Biophys Res Commun; 2010 Jul; 398(3):462-6. PubMed ID: 20599702
[TBL] [Abstract][Full Text] [Related]
15. Calycosin entered HUVECs and ameliorated AGEs-promoted cell apoptosis via the Bcl-2 pathway.
Xu YH; Xiong J; Wang SS; Tang D; Wang RS; Zhu Q
J Nat Med; 2014 Jan; 68(1):163-72. PubMed ID: 23797737
[TBL] [Abstract][Full Text] [Related]
16. A PKC-beta inhibitor prompts the HUVECs apoptosis-induced by advanced glycation end products.
Wang SS; Xu YH; Feng L; Zhu Q; He B
Pharmazie; 2011 Nov; 66(11):881-7. PubMed ID: 22204135
[TBL] [Abstract][Full Text] [Related]
17. Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes.
Ravassa S; Zudaire A; Carr RD; Díez J
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1361-72. PubMed ID: 21278133
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2011 Sep; 43(10):731-4. PubMed ID: 21932180
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells.
Ding L; Zhang J
Acta Pharmacol Sin; 2012 Jan; 33(1):75-81. PubMed ID: 22120969
[TBL] [Abstract][Full Text] [Related]
20. Linagliptin protects human chondrogenic ATDC5 cells against advanced glycation end products (AGEs)-induced apoptosis via a mitochondria-dependent pathway.
Zhang Y; Huang X; Yuan Y
Chem Biol Interact; 2020 Jan; 315():108901. PubMed ID: 31733186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
